Here is What Hedge Funds Think About Pacira Biosciences Inc (PCRX)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (...
Posts Tagged ‘NASDAQ:PCRX’
Did Hedge Funds Make The Right Call On Pacira Biosciences Inc (PCRX)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However...
Hedge Funds Souring On Pacira Biosciences Inc (PCRX)
In this article you are going to find out whether hedge funds think Pacira Biosciences Inc (NASDAQ:PCRX) is a good investment right now. We like to check...
Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted...
2019 Review: Top Hedge Fund Stocks vs. Pacira BioSciences, Inc. (PCRX)
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019. Among them, Facebook and Microsoft...
Is Pacira BioSciences, Inc. (PCRX) A Good Stock To Buy?
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Facebook...
Is Pacira BioSciences, Inc. (PCRX) A Good Stock To Buy?
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due...
Here’s What Hedge Funds Think About Pacira Pharmaceuticals Inc (PCRX)
The government requires hedge funds and wealthy investors that crossed the $100 million equity holdings threshold are required to file a report that shows...
Is Pacira Pharmaceuticals Inc (PCRX) A Good Stock To Buy ?
Before we spend countless hours researching a company, we’d like to analyze what insiders, hedge funds and billionaire investors think of the stock...
Pacira Pharmaceuticals Inc (PCRX): Are Hedge Funds Right About This Stock?
After several tireless days we have finished crunching the numbers from the more than 700 13F filings issued by the elite hedge funds and other investment...
13G Filing: Point72 Asset Management and Pacira Pharmaceuticals Inc. (PCRX)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 11 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
13G Filing: Healthcor Management LP and Pacira Pharmaceuticals Inc. (PCRX)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 15 – SEC Filing SECURITIES & EXCHANGE COMMISSION...
13G Filing: Partner Fund Management and Pacira Pharmaceuticals Inc (PCRX)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
Should You Buy Pacira Pharmaceuticals Inc (PCRX)?
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined...
Should You Be Bullish on Home Bancshares Inc (HOMB), Calpine Corporation (CPN) & Two Other Stocks?
Are Home Bancshares Inc (NASDAQ:HOMB), Calpine Corporation (NYSE:CPN), Pacira Pharmaceuticals Inc (NASDAQ:PCRX), and Rent-A-Center Inc (NASDAQ:RCII...
Mattress Firm (MFRM) Acquisition Powers 40 North Management to Impressive Q3 Returns
David S. Winter and David J. Millstone‘s 40 North Management is one of the 749 hedge funds in our database that filed a 13F for the June 30 SEC...
Biogen (BIIB) Helped Healthcare Funds Like This One Dominate The Third Quarter
The majority of hedge funds and other top money managers tend to have a long-term focus when they make investments. This means that retail investors can...
Here’s Why CareDx Inc (CDNA), Netflix Inc. (NFLX) and Three Other Stocks Are Losing Ground Today
Markets are strong today, ahead of an important two-day policy meeting of the US Fed. Markets expect the interest rates to remain unchanged and the official...
A Look at Visium Asset Management’s Top Picks Amid Loud Insider Trading Case
Jacob Gottlieb’s multi-billion-dollar hedge fund Visium Asset Management LP has been making headlines earlier today, as federal authorities filed criminal...
Hedge Funds Hated These Healthcare Stocks in Q1
The healthcare sector is down by about 3.75% so far this year, after enjoying a lengthy bull run into the middle of 2015. While the current breather could...
Why Are These Five Stocks Surging on Tuesday?
Seeing as all three indexes have surged more than 1% in morning trading as the Federal Reserve promises interest rates will still be low for a while,...
Should You Buy Pacira Pharmaceuticals Inc (PCRX)?
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the...
A Look at 5 Major Stock Market Gainers and the Drivers Behind Their Sharp Uptrend
As stock markets are trading in a narrow range with a slight negative bias today, five stocks are showing significant upside price movement backed by...
Four Hot Biotechs Among The Day’s Big Winners
On a day when Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is deep in the red following the release of its third quarter earnings, four other biotech stocks...
Goldman Sachs And Hedge Funds See Big Things For These Small-caps
The recent pull back in the Russell 2000 index left it down about 10% on a year-to-date basis just before the start of this month. During October these...
What Hedge Funds Think Of Goldman Sachs’ Top Healthcare Takeover Targets
A surge of M&A activity involving healthcare, financial, and retail companies boosted the value of deals in July to over $430 billion, resulting...
Baker Bros. Advisors Buys More DBV Technologies S.A. (DBVT); Visium Asset Management Goes Long On Pacira Pharmaceuticals Inc. (PCRX)
According to a freshly-amended 13G filing with the SEC, Baker Bros. Advisors LP, founded by Julian Baker and Felix Baker, revealed it owns 15.1% of DBV...
Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?
Should Pacira Pharmaceuticals Inc (NASDAQ:PCRX) investors track the following data? To the average investor, there are many methods market participants...
This Metric Says You Are Smart to Buy Neurocrine Biosciences, Inc. (NBIX)
Is it smart to be bullish on Neurocrine Biosciences, Inc. (NASDAQ:NBIX)? In the financial world, there are dozens of indicators investors can use to...
Hedge Funds Are Buying Impax Laboratories Inc (IPXL)
Is Impax Laboratories Inc (NASDAQ:IPXL) a good investment? At the moment, there are tons of indicators shareholders can use to analyze publicly traded...
Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?
To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies. Some of the most under-the-radar are...
Santarus, Inc. (SNTS), Pacira Pharmaceuticals Inc (PCRX): Make Money in These Growing Pharma Stocks the Easy Way
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you’d like to add some pharmaceutical stocks to...
Here is What Hedge Funds Think About Pacira Pharmaceuticals Inc (PCRX)
Is Pacira Pharmaceuticals Inc (NASDAQ:PCRX) a superb investment right now? Hedge funds are in an optimistic mood. The number of long hedge fund positions...
Neurocrine Biosciences, Inc. (NBIX): Are Hedge Funds Right About This Stock?
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was in 16 hedge funds’ portfolio at the end of the first quarter of 2013. NBIX has experienced an increase...
Bearish Options Active On Market Vectors Gold Miners ETF (GDX)
Market Vectors Gold Miners ETF (NYSEARCA:GDX) – Big prints in Market Vectors Gold Miners ETF (NYSEARCA:GDX) put options on Tuesday morning indicate...
Hedge Funds Are Buying Aegerion Pharmaceuticals, Inc. (AEGR)
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was in 14 hedge funds’ portfolio at the end of the fourth quarter of 2012. AEGR has seen an increase...
Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?: Impax Laboratories Inc (IPXL), Pacira Pharmaceuticals Inc (PCRX)
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was in 14 hedge funds’ portfolio at the end of December. AEGR has experienced an increase in enthusiasm...
Do Hedge Funds and Insiders Love Pacira Pharmaceuticals Inc (PCRX)? – Intercept Pharmaceuticals Inc (ICPT), Aegerion Pharmaceuticals, Inc. (AEGR)
Pacira Pharmaceuticals Inc (NASDAQ:PCRX) was in 9 hedge funds’ portfolio at the end of December. PCRX shareholders have witnessed a decrease in...
